Evaluation and Management of Dyspnea in Hypermobile Ehlers-Danlos Syndrome and Generalized Hypermobility Spectrum Disorder: Protocol for a Pilot and Feasibility Randomized Controlled Trial
Authors:
- Dmitry RozenbergDRDmitry Rozenberg
- Noor Al KaabiNKNoor Al Kaabi
- Encarna Camacho PerezEPEncarna Camacho Perez
- Sahar NourouzpourSNSahar Nourouzpour
- Laura Lopez-HernandezLLLaura Lopez-Hernandez
- Laura McGillisLMLaura McGillis
- Ewan GoligherEGEwan Goligher
- W Darlene ReidWRW Darlene Reid
- Chung-Wai ChowCCChung-Wai Chow
- Clodagh M RyanCRClodagh M Ryan
- Dinesh KumbhareDKDinesh Kumbhare
- Ella HusztiEHElla Huszti
Open Access
- 20 March 2023
- journal article
- research article
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 12 (1) , e44832
Abstract
Background: Dyspnea is a prevalent symptom in individuals with hypermobile Ehlers-Danlos Syndrome (hEDS) and generalized hypermobility spectrum disorder (G-HSD), yet its contributors have not been identified. One known contributor to dyspnea is respiratory muscle weakness. The feasibility and effectiveness of inspiratory muscle training (IMT) in combination with standard-of-care rehabilitation (aerobic, resistance, neuromuscular stabilization, and balance and proprioception exercises) in improving respiratory muscle strength and patient-reported outcomes in patients with hEDS or G-HSD have not been evaluated. Objective: This study aims to evaluate dyspnea, respiratory muscle strength, and patient-reported outcome measures (PROMs) in hEDS or G-HSD compared with healthy controls and to assess the feasibility of a randomized controlled trial of IMT and standard-of-care rehabilitation for improving respiratory muscle strength, exercise capacity, and PROMs compared with standard-of-care rehabilitation in hEDS and G-HSD. Methods: The study will include 34 participants with hEDS or G-HSD and 17 healthy, age- and sex-matched controls to compare respiratory muscle structure and function and PROMs. After baseline assessments, participants with hEDS or G-HSD will be randomized into the intervention group and provided IMT combined with Ehlers-Danlos Syndrome standard-of-care rehabilitation or into the usual care group, and provided only standard-of-care rehabilitation for 8 weeks. The intervention group will be prescribed IMT in their home environment using the POWERbreathe K5 IMT device (POWERbreathe International Ltd). IMT will comprise 2 daily sessions of 30 breaths for 5 days per week, with IMT progressing from 20% to 60% of the baseline maximal inspiratory pressure (MIP) over an 8-week period. Feasibility will be assessed through rates of recruitment, attrition, adherence, adverse events, and participant satisfaction. The primary pilot outcome is MIP change over an 8-week period in hEDS or G-HSD. Secondary outcomes will include the evaluation of dyspnea using Medical Research Council Scale and 18-point qualitative dyspnea descriptors; diaphragmatic thickening fraction using ultrasound; respiratory muscle endurance; pulmonary function; prefrontal cortical activity using functional near-infrared spectroscopy; aerobic capacity during cardiopulmonary exercise testing; quality of life using Short Form-36; and scores from the Depression, Anxiety, and Stress scale-21. These measures will also be performed once in healthy controls to compare normative values. Multivariable regression will be used to assess the contributors to dyspnea. Paired 2-tailed t tests will be used to assess the changes in MIP and secondary measures after 8 weeks of IMT. Results: Study recruitment began in August 2021 and, with several disruptions owing to COVID-19, is expected to be completed by December 2023. Conclusions: This study will provide a better understanding of the factors associated with dyspnea and the feasibility and effectiveness of IMT combined with standard-of-care rehabilitation. IMT may be a novel therapeutic strategy for improving respiratory muscle function and patient-reported outcomes in individuals with hEDS or G-HSD. Trial Registration: ClinicalTrials.gov NCT04972565; https://clinicaltrials.gov/ct2/show/NCT04972565 International Registered Report Identifier (IRRID): DERR1-10.2196/44832Keywords
All Related Versions
This publication has 78 references indexed in Scilit:
- Evidence for cognitive–behavioral strategies improving dyspnea and related distress in COPDInternational Journal of Chronic Obstructive Pulmonary Disease, 2013
- Effects of inspiratory muscle training on dynamic hyperinflation in patients with COPDInternational Journal of Chronic Obstructive Pulmonary Disease, 2012
- Activation of the Prefrontal Cortex Is Associated with Exertional Dyspnea in Chronic Obstructive Pulmonary DiseaseRespiration, 2011
- Qualitative aspects of exertional dyspnea in patients with restrictive lung diseaseMultidisciplinary Respiratory Medicine, 2010
- Impaired Heart Rate Recovery and Chronotropic Incompetence in Patients With Heart Failure With Preserved Ejection FractionCirculation: Heart Failure, 2010
- Asthma and airways collapse in two heritable disorders of connective tissueAnnals of the Rheumatic Diseases, 2007
- Impulse oscillometry: an alternative modality to the conventional pulmonary function test to categorise obstructive pulmonary disordersClinical and Experimental Medicine, 2007
- Quality of Life in Patients With Postural Tachycardia SyndromeMayo Clinic Proceedings, 2002
- The MOS 36-Item Short-Form Health Survey (SF-36)Medical Care, 1993
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987